CDKN2A and melanoma: Our results (on FFPE tissue samples) showed that copy number changes in these genes were present only at later stages of the disease (Clark stage IV and V), although Rákosy and colleagues30 showed that deletion of the 9p21 region (CDKN2A/B) is also present in early stages of melanoma.